A new Alzheimer’s drug, lecanemab, may slow disease progression and offer patients up to four extra years of stable health.

In 2025, researchers created a stable version called diAcCA, and early lab results are promising. The compound improved ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

The Alzheimer's Association international conference highlighted the roles exercise, lead exposure, blood tests and food ...

The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...

Families across Georgia are finding new hope in the fight against Alzheimer’s disease, thanks to promising treatments at ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...

In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

Researchers at the Carney Institute for Brain Science have identified electrical activity in the brain that could predict ...

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

Zanesville, OH- Every 65 seconds, someone in the U.S. receives a troubling diagnosis.  Alzheimer’s disease, which has no cure ...

In the early stages of Alzheimer’s disease, people may have trouble following conversations, repeat themselves, or struggle ...